301047 Stock Overview
Provides recombinant protein and antibody reagents for life science researchers worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Sino Biological,Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥65.28 |
| 52 Week High | CN¥89.09 |
| 52 Week Low | CN¥53.51 |
| Beta | 0.99 |
| 1 Month Change | -2.29% |
| 3 Month Change | 14.09% |
| 1 Year Change | -21.24% |
| 3 Year Change | -65.42% |
| 5 Year Change | n/a |
| Change since IPO | -74.86% |
Recent News & Updates
Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 04
Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up
Sep 30Recent updates
Sino BiologicalInc's (SZSE:301047) Shareholders Have More To Worry About Than Only Soft Earnings
Nov 04Sino Biological,Inc.'s (SZSE:301047) Shares Climb 31% But Its Business Is Yet to Catch Up
Sep 30Sino BiologicalInc (SZSE:301047) Is Paying Out A Dividend Of CN¥2.00
May 21Sino Biological,Inc.'s (SZSE:301047) P/E Is Still On The Mark Following 26% Share Price Bounce
May 08Beyond Lackluster Earnings: Potential Concerns For Sino BiologicalInc's (SZSE:301047) Shareholders
May 06Shareholder Returns
| 301047 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -5.2% | -4.1% | -2.6% |
| 1Y | -21.2% | -17.9% | 9.7% |
Return vs Industry: 301047 underperformed the CN Biotechs industry which returned -17.9% over the past year.
Return vs Market: 301047 underperformed the CN Market which returned 9.7% over the past year.
Price Volatility
| 301047 volatility | |
|---|---|
| 301047 Average Weekly Movement | 8.0% |
| Biotechs Industry Average Movement | 8.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.8% |
Stable Share Price: 301047 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301047's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | 953 | Zhang Jie | www.sinobiological.com |
Sino Biological,Inc. provides recombinant protein and antibody reagents for life science researchers worldwide. It offers recombinant proteins, antibodies, cDNA clones, kits, and other reagents that are used in the areas of cancer, cardiovascular biology, cell and developmental biology, epigenetics, immunology, neuroscience, signal transduction, and stem cells.
Sino Biological,Inc. Fundamentals Summary
| 301047 fundamental statistics | |
|---|---|
| Market cap | CN¥7.94b |
| Earnings (TTM) | CN¥154.25m |
| Revenue (TTM) | CN¥635.28m |
51.5x
P/E Ratio12.5x
P/S RatioIs 301047 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301047 income statement (TTM) | |
|---|---|
| Revenue | CN¥635.28m |
| Cost of Revenue | CN¥155.61m |
| Gross Profit | CN¥479.67m |
| Other Expenses | CN¥325.42m |
| Earnings | CN¥154.25m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.27 |
| Gross Margin | 75.51% |
| Net Profit Margin | 24.28% |
| Debt/Equity Ratio | 0% |
How did 301047 perform over the long term?
See historical performance and comparisonDividends
3.1%
Current Dividend Yield166%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 20:53 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sino Biological,Inc. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaying Fu | China International Capital Corporation Limited |
| Zhu Chen | Citic Securities Co., Ltd. |
| Kai Wang | Citic Securities Co., Ltd. |